1. Home
  2. AMX vs REGN Comparison

AMX vs REGN Comparison

Compare AMX & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America Movil S.A.B. de C.V.

AMX

America Movil S.A.B. de C.V.

HOLD

Current Price

$24.96

Market Cap

72.5B

ML Signal

HOLD

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$759.24

Market Cap

68.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMX
REGN
Founded
2000
1988
Country
Mexico
United States
Employees
178468
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.5B
68.8B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
AMX
REGN
Price
$24.96
$759.24
Analyst Decision
Buy
Buy
Analyst Count
5
25
Target Price
$24.60
$830.16
AVG Volume (30 Days)
1.6M
762.9K
Earning Date
04-21-2026
04-29-2026
Dividend Yield
2.14%
0.55%
EPS Growth
N/A
8.19
EPS
N/A
18.95
Revenue
N/A
$5,872,227,000.00
Revenue This Year
$4.89
$12.45
Revenue Next Year
$4.73
$10.13
P/E Ratio
$15.78
$40.24
Revenue Growth
N/A
20.82
52 Week Low
$17.98
$541.00
52 Week High
$28.46
$821.11

Technical Indicators

Market Signals
Indicator
AMX
REGN
Relative Strength Index (RSI) 35.26 78.13
Support Level $24.75 $738.17
Resistance Level $26.39 $783.87
Average True Range (ATR) 0.62 20.75
MACD -0.12 10.35
Stochastic Oscillator 9.32 93.05

Price Performance

Historical Comparison
AMX
REGN

About AMX America Movil S.A.B. de C.V.

America Movil is the largest telecom carrier in Latin America, serving about 330 million wireless customers across the region. It also provides fixed-line phone, internet access, and television services in most of the countries it serves. Mexico is the firm's largest market, providing about 35% of service revenue. Movil dominates the Mexican wireless market with about 60% customer share and also serves about half of the country's fixed-line internet access customers. Brazil, its second most important market, provides about 20% of service revenue. Movil sold its low-margin wireless resale business in the US to Verizon in 2021 and now owns a 1.4% stake in the US telecom giant. The firm also holds a 61% stake in Telekom Austria.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: